Ting Chen

Ting Chen

Auto-generated profile, based on publicly available information

Ting Chen

Department of Nuclear Medicine, Fuwai Yunnan Cardiovascular Hospital, Chinese Academy of Medical Sciences (Affiliated Cardiovascular Hospital of Kunming Medical University), Kunming, 528 Shahe North Road, Wuhua District, China.

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2024 in eClinicalMedicine
Verified
Journal Article
Open access
FHFei Hou
Fei Hou
YZYun Zhu
Yun Zhu
HZHongbo Zhao
Hongbo Zhao
HCHaolin Cai
Haolin Cai
YWYinghui Wang
Yinghui Wang
TCTing Chen
Ting Chen
The survival rate of patients with distant metastasis (DM) of papillary thyroid carcinoma (PTC) is significantly reduced. It is of great significance to find an effective method for early prediction of the risk of DM for formulating individualized diagnosis and treatment plans and improving prognosis. Previous studies have significant limitations, and it is still necessary to develop new models for predicting the risk of DM of PTC. We aimed to develop and validate interpretable machine learning (ML) models for early prediction of DM in patients with PTC using a multicenter cohort. We collected data on patients with PTC who were admitted between June 2013 and May 2023. Data from 1430 patients at Yunnan Cancer Hospital (YCH) served as the training and internal validation set, while data from 434 patients at the First Affiliated Hospital of Kunming Medical University (KMU 1st AH) was used as the external test set. Nine ML methods such as random forest (RF) were used to construct the model. Model prediction performance was compared using evaluation indicators such as the area under the receiver operating characteristic curve (AUC). The SHapley Additive exPlanation (SHAP) method was used to rank the feature importance and explain the final model. Among the nine ML models, the RF model performed the best. The RF model accurately predicted the risk of DM in patients with PTC in both the internal validation of the training set [AUC: 0.913, 95% confidence interval (CI) (0.9075–0.9185)] and the external test set [AUC: 0.8996, 95% CI (0.8483–0.9509)]. The calibration curve showed high agreement between the predicted and observed risks. In the sensitivity analysis focusing on DM sites of PTC, the RF model exhibited outstanding performance in predicting “lung-only metastasis” showing high AUC, specificity, sensitivity, F1 score, and a low Brier score. SHAP analysis identified variables that contributed to the model predictions. An online calculator based on the RF model was developed and made available for clinicians at https://predictingdistantmetastasis.shinyapps.io/shiny1/. 11 variables were included in the final RF model: age of the patient with PTC, whether the tumor size is > 2 cm, whether the tumor size is ≤ 1 cm, lymphocyte (LYM) count, monocyte (MONO) count, monocyte/lymphocyte ratio (MLR), thyroglobulin (TG) level, thyroid peroxidase antibody (TPOAb) level, whether the T stage is T1/2, whether the T stage is T3/4, and whether the N stage is N0. On the basis of large-sample and multicenter data, we developed and validated an explainable ML model for predicting the risk of DM in patients with PTC. The model helps clinicians to identify high-risk patients early and provides a basis for individualized patient treatment plans. This work was supported by the 10.13039/501100001809 National Natural Science Foundation of China (No. 81960426, 82360345 and 82001986), the Outstanding Youth Science Foundation of Yunnan Basic Research Project (No. 202401AY070001-316), 10.13039/100007471 Yunnan Province Applied and Basic Research Foundation (No. 202401AT070008), and 10.13039/501100018576 Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province .

9 May 2024 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
XPXiaoqi Peng
Xiaoqi Peng
HZHongbo Zhao
Hongbo Zhao
LYLijuan Ye
Lijuan Ye
FHFei Hou
Fei Hou
ZYZihan Yi
Zihan Yi
TCTing Chen
Ting Chen
Purpose: The rising global high incidence of differentiated thyroid carcinoma (DTC) has led to a significant increase in patients presenting with lung metastasis of DTC (LMDTC). This population poses a significant challenge in clinical practice, necessitating the urgent development of effective risk stratification methods and predictive tools for lung metastasis. Experimental Design: Through proteomic analysis of large samples of primary lesion and dual validation employing parallel reaction monitoring and IHC, we identified eight hub proteins as potential biomarkers. By expanding the sample size and conducting statistical analysis on clinical features and hub protein expression, we constructed three risk prediction models. Results: This study identified eight hub proteins—SUCLG1/2, DLAT, IDH3B, ACSF2, ACO2, CYCS, and VDAC2—as potential biomarkers for predicting LMDTC risk. We developed and internally validated three risk prediction models incorporating both clinical characteristics and hub protein expression. Our findings demonstrated that the combined prediction model exhibited optimal predictive performance, with the highest discrimination (AUC: 0.986) and calibration (Brier score: 0.043). Application of the combined prediction model within a specific risk threshold (0–0.97) yielded maximal clinical benefit. Finally, we constructed a nomogram based on the combined prediction model. Conclusions: As a large sample size study in LMDTC research, the identification of biomarkers through primary lesion proteomics and the development of risk prediction models integrating clinical features and hub protein biomarkers offer valuable insights for predicting LMDTC and establishing personalized treatment strategies.

5 August 2023 in Research Square
Verified
Preprint
Open access
PDF file
TCTing Chen
Ting Chen
HJHua Jiang
Hua Jiang
LLLin Lu
Lin Lu
LYLijuan Ye
Lijuan Ye
FHFei Hou
Fei Hou
XZXihua Zheng
Xihua Zheng
Circular RNAs (circRNAs) have been proved have a major impact on tumorigenesis. Whereas, the specific regulation of circRNAs during lung cancer progression is still need further investigation. Here, we found hsa_circ_0078767 was lowly expressed in lung cancer. Through CCK-8, colony formation, EdU staining, and flow cytometer apoptosis assays. We found that up-regulation of hsa_circ_0078767 repressed lung cancer cells proliferation and facilitated cell apoptosis in vitro and in vivo. Furthermore, we identified the regulatory function of hsa_circ_0078767 on ferroptosis during the malignant development of lung cancer. Elevated iron, Fe2+, and ROS levels was found in hsa_circ_0078767 overexpressed lung cancer cells. Ferroptosis activator erastin reduces the cell viability, and the hsa_circ_0078767 overexpression reinforced erastin-induced inhibitory effect on lung cancer cells. Mechanically, hsa_circ_0078767 sponged miR-330-3p to affect p53 expression. Up-regulation of miR-330-3p and knockdown of p53 reversed the role of hsa_circ_0078767 overexpression on lung cancer cells. Taken together, hsa_circ_0078767 may be a new research highlights for inhibiting lung cancer by promoting ferroptosis in lung cancer cells.

16 May 2026 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
JLJinyong Luo
Jinyong Luo
LJLihua Ji
Lihua Ji
QDQingfei Dong
Qingfei Dong
QKQingqian Kong
Qingqian Kong
TCTing Chen
Ting Chen
WYWeihong Yuan
Weihong Yuan
Objective To assess the clinical value of dual-time-point planar imaging and SPECT/CT tomographic imaging of 99mTc-PYP in diagnosing transthyretin cardiac amyloidosis (ATTR-CA), and to compare the diagnostic performance of different imaging time points and methods. Methods A retrospective analysis of 98 suspected CA patients (ATTR-CA 12; AL-CA 23; non-CA 63). Early imaging at 1 h and delayed imaging at 3 h included planar and tomographic imaging. Evaluations used the Perugini visual grading, heart-to-contralateral lung uptake ratio (H/CL), and tomographic semi-quantitative scoring. Pathology biopsy and genetic testing served as the gold standard. Sensitivity, specificity, and accuracy were compared across methods. Results Delayed tomographic imaging for ATTR-CA achieved a sensitivity of 100.0%, specificity of 96.5%, and accuracy of 96.9%, the best among all methods. The earliest Perugini scoring method had the lowest accuracy (80.6%), and early imaging using the H/CL method had the lowest diagnostic sensitivity (58.3%). SPECT/CT imaging at 3 h provides significant incremental diagnostic value compared to planar imaging and offers the greatest benefits, Cases that were missed during the initial review have been reclassified.Delayed imaging was superior to early imaging overall, and tomographic imaging significantly reduced false positives caused by blood-pool artifacts. Conclusion Dual-time-point 99mTc-PYP imaging with tomographic imaging can significantly improve the diagnostic accuracy for ATTR-CA, with delayed SPECT/CT performing best. For cases with atypical early imaging or diagnostic difficulty due to blood-pool tracer distribution, when Perugini grade is 2, early H/CL ≤ 1.5 or delayed H/CL ≤ 1.3, or in highly suspected cases where early imaging provides insufficient diagnostic evidence, routine inclusion of delayed SPECT/CT in the imaging workflow for suspected ATTR-CA is recommended to optimize subtyping and guide subsequent therapy.

15 July 2024
Verified
Other
Open access
XPXiaoqi Peng
Xiaoqi Peng
HZHongbo Zhao
Hongbo Zhao
LYLijuan Ye
Lijuan Ye
FHFei Hou
Fei Hou
ZYZihan Yi
Zihan Yi
TCTing Chen
Ting Chen
Table S2. Relevant clinical information of 44 LMDTC and 25 NMDTC patients used for 4D Label-free proteomic analysis, PRM, and IHC dual validation

15 July 2024
Verified
Other
Open access
XPXiaoqi Peng
Xiaoqi Peng
HZHongbo Zhao
Hongbo Zhao
LYLijuan Ye
Lijuan Ye
FHFei Hou
Fei Hou
ZYZihan Yi
Zihan Yi
TCTing Chen
Ting Chen
Table S7. Validation results of candidate hub proteins by PRM, among which 17 hub proteins are statistically significant